Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$265K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Jun 24 | CCCC | C4 Therapeutics, Inc. | AGRANT◆ | 62,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 4 | MBX | MBX Biosciences, Inc. | AGRANT◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| May 1 | MBX | MBX Biosciences, Inc. | AGRANT◆ | 74,249 | — | — | — | Open the original filing on SEC.gov |
| May 1 | MBX | MBX Biosciences, Inc. | AGRANT | 11,938 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | ORIC | Oric Pharmaceuticals, Inc. | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 22, 2025 | MBX | MBX Biosciences, Inc. | AGRANT◆↺ | 0 | — | — | — | Open the original filing on SEC.gov |
| Nov 6, 2025 | MBX | MBX Biosciences, Inc. | AGRANT◆↺ | 33,751 | — | — | — | Open the original filing on SEC.gov |
| Oct 17, 2025 | MBX | MBX Biosciences, Inc. | PBUY | 20,000 | $13.25 | $265K | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | CCCC | C4 Therapeutics, Inc. | AGRANT◆ | 35,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | MBX | MBX Biosciences, Inc. | AGRANT◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |